Intrinsic Value of S&P & Nasdaq Contact Us

Morphic Holding, Inc. MORF NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
38/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$57.00
+0%

Financial Health Score — MORF

Morphic Holding, Inc. (MORF) has an overall financial health rating of C+ with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2024-08-15.

C+
Overall Rating
2024-08-15

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2024-08-15 C+ -/5 -/5 -/5 -/5 -/5 -/5
2024-08-14 C+ -/5 -/5 -/5 -/5 -/5 -/5
2024-08-13 C+ -/5 -/5 -/5 -/5 -/5 -/5
2024-08-12 C+ -/5 -/5 -/5 -/5 -/5 -/5
2024-08-09 C+ -/5 -/5 -/5 -/5 -/5 -/5
2024-08-08 C+ -/5 -/5 -/5 -/5 -/5 -/5
2024-08-07 C+ -/5 -/5 -/5 -/5 -/5 -/5
2024-08-06 C+ -/5 -/5 -/5 -/5 -/5 -/5
2024-08-05 C+ -/5 -/5 -/5 -/5 -/5 -/5
2024-08-02 C+ -/5 -/5 -/5 -/5 -/5 -/5
2024-08-01 C+ -/5 -/5 -/5 -/5 -/5 -/5
2024-07-31 C+ -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message